Abstract

This paper describes the purification and some of the properties of an enzyme from human spleen that catalyzes the hydrolysis of sphingomyelin with the formation of ceramide and phosphoryl choline. The enzyme, which is located in the subcellular particulate fraction that sediments between 700 and 8500 g, is readily made soluble and has been partially purified. Its pH optimum is between 4.5 and 5.0. It is unaffected by divalent cations, chelating agents, and sulfhydryl reagents, but is inhibited by phosphate. The enzyme attacks sphingomyelin and dihydrosphingomyelin, but is inactive toward sphingosine phosphoryl choline, O-acetylsphingomyelin, and lecithin. In some of its properties, the enzyme from human spleen is different from the previously studied sphingomyelinase from rat tissues. The enzyme is absent or markedly reduced in spleens from patients with classical and visceral varieties of Niemann-Pick disease, but is present in normal amounts in the late infantile type of the disease. In the present study another enzyme, this one magnesium-dependent, capable of catalyzing the cleavage of sphingomyelin has been detected in the spleens of patients with the classical form of Niemann-Pick disease. Some implications of these findings for theories of the metabolic defect in Niemann-Pick disease are discussed.

Highlights

  • This paper describes the purification and some of the properties of an enzyme from human spleen that catalyzes the hydrolysis of sphingomyelin with the formation of ceramide and phosphoryl choline

  • Perfringens, attacks sphingomyelin, with the cleavage of phosphoryl choline and formation of a ceramide [1]. Such phospholipases are relatively nonspecific : they attack lecithin and “cephalins.” In the present report, we describe the partial purification and some of the properties of a sphingomyelinase from human spleen that is specific for sphingomyelin and dihydrosphingomyelin, and that hydrolyzes the bond between ceramide and phosphoryl choline

  • The spleen is prominently involved with abnormal accumulation of sphingomyelin in NiemannPick disease, and the study of the biochemistry of this condition is of interest for its own sake and within the general topic of the catabolism of sphingomyelin in the intact organism

Read more

Summary

Introduction

This paper describes the purification and some of the properties of an enzyme from human spleen that catalyzes the hydrolysis of sphingomyelin with the formation of ceramide and phosphoryl choline. Perfringens, attacks sphingomyelin, with the cleavage of phosphoryl choline and formation of a ceramide [1] Such phospholipases are relatively nonspecific : they attack lecithin and “cephalins.” In the present report, we describe the partial purification and some of the properties of a sphingomyelinase from human spleen that is specific for sphingomyelin and dihydrosphingomyelin, and that hydrolyzes the bond between ceramide and phosphoryl choline. The spleen is prominently involved with abnormal accumulation of sphingomyelin in NiemannPick disease, and the study of the biochemistry of this condition is of interest for its own sake and within the general topic of the catabolism of sphingomyelin in the intact organism For this reason, we have examined the sphingomyelinase activity of spleens from patients suffering from Niemann-Pick disease of several types. Some of the properties of the enzyme from human tissues, described here for the first time, are different from those of the rat enzyme

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.